首页 > 最新文献

Clinical journal of oncology nursing最新文献

英文 中文
Integrating Artificial Intelligence Into Cancer Care: Enhancing Nursing Practice and Bridging Disparities. 将人工智能融入癌症护理:加强护理实践和弥合差距。
IF 1.2 4区 医学 Q3 NURSING Pub Date : 2025-08-04 DOI: 10.1188/25.CJON.345-351
Youran Lee, Yan Wang, Osborn Owusu Ansah, Jung In Park, Mary Louise Affronti, Michael P Cary

Artificial intelligence (AI) in cancer care has the potential to transform nursing practice, reduce cancer disparities, and enhance patient outcomes across the continuum of care from prevention, screening, and treatment to su.

癌症护理中的人工智能(AI)有可能改变护理实践,减少癌症差异,并在从预防、筛查、治疗到康复的整个护理过程中提高患者的治疗效果。
{"title":"Integrating Artificial Intelligence Into Cancer Care: Enhancing Nursing Practice and Bridging Disparities.","authors":"Youran Lee, Yan Wang, Osborn Owusu Ansah, Jung In Park, Mary Louise Affronti, Michael P Cary","doi":"10.1188/25.CJON.345-351","DOIUrl":"10.1188/25.CJON.345-351","url":null,"abstract":"<p><p>Artificial intelligence (AI) in cancer care has the potential to transform nursing practice, reduce cancer disparities, and enhance patient outcomes across the continuum of care from prevention, screening, and treatment to su.</p>","PeriodicalId":10350,"journal":{"name":"Clinical journal of oncology nursing","volume":"29 4","pages":"345-351"},"PeriodicalIF":1.2,"publicationDate":"2025-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12339281/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144834247","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Normal Saline Push-Pause Advantage for Implanted Port Patency: A Comparative Study. 生理盐水推停优势对植入端口开放的比较研究。
IF 1.2 4区 医学 Q3 NURSING Pub Date : 2025-08-04 DOI: 10.1188/25.CJON.329-333
Anna Mueller, Erin N Smith, Caroline Apter, Jennifer A Mitchell, Tracy Shelmire, Meredith Lucas, Bridget Royal-Coleman, Olawunmi Obisesan

Background: Implanted ports are essential for long-term vascular access. However, port occlusions can lead to treatment delays and reduced quality of life. Concerns about the safety of heparin have led to the exploration of safer alternatives.

Objectives: This study aimed to assess the effectiveness of 20 ml normal saline using the push-pause flush technique, compared to heparin, in preventing implanted port occlusions.

Methods: A cohort study of 538 patients with implanted ports was conducted over five months. Data on demographics, port type, locking solution, occlusions, and interventions were collected. A transition from heparin-based flushing to normal saline-based flushing occurred during the study.

Findings: Preliminary analysis showed low overall port occlusion rates, regardless of the locking solution used. A Fisher's exact test revealed no significant association between the type of locking solution and port occlusion. Interim findings suggest that when used with the pulsatile flush technique, normal saline may be as effective as heparin in maintaining port patency. Additional research is needed to assess the long-term implications of using saline as a locking solution.

背景:植入式端口对于长期血管通路至关重要。然而,肺脏闭塞可导致治疗延误和生活质量下降。对肝素安全性的担忧导致了对更安全替代品的探索。目的:本研究旨在评估20ml生理盐水使用推停冲洗技术,与肝素相比,在预防植入端口阻塞方面的有效性。方法:对538例移植端口患者进行为期5个月的队列研究。收集了人口统计学、端口类型、锁定解决方案、闭塞和干预措施的数据。在研究期间发生了从肝素为基础的潮红到正常的盐为基础的潮红的转变。研究结果:初步分析显示,无论使用何种锁定溶液,总的端口闭塞率都很低。Fisher精确测试显示锁紧溶液的类型和端口阻塞之间没有显著的关联。中期研究结果表明,当与搏动冲洗技术一起使用时,生理盐水在维持肝素通畅方面可能与肝素一样有效。需要进一步的研究来评估使用生理盐水作为锁定溶液的长期影响。
{"title":"Normal Saline Push-Pause Advantage for Implanted Port Patency: A Comparative Study.","authors":"Anna Mueller, Erin N Smith, Caroline Apter, Jennifer A Mitchell, Tracy Shelmire, Meredith Lucas, Bridget Royal-Coleman, Olawunmi Obisesan","doi":"10.1188/25.CJON.329-333","DOIUrl":"10.1188/25.CJON.329-333","url":null,"abstract":"<p><strong>Background: </strong>Implanted ports are essential for long-term vascular access. However, port occlusions can lead to treatment delays and reduced quality of life. Concerns about the safety of heparin have led to the exploration of safer alternatives.</p><p><strong>Objectives: </strong>This study aimed to assess the effectiveness of 20 ml normal saline using the push-pause flush technique, compared to heparin, in preventing implanted port occlusions.</p><p><strong>Methods: </strong>A cohort study of 538 patients with implanted ports was conducted over five months. Data on demographics, port type, locking solution, occlusions, and interventions were collected. A transition from heparin-based flushing to normal saline-based flushing occurred during the study.</p><p><strong>Findings: </strong>Preliminary analysis showed low overall port occlusion rates, regardless of the locking solution used. A Fisher's exact test revealed no significant association between the type of locking solution and port occlusion. Interim findings suggest that when used with the pulsatile flush technique, normal saline may be as effective as heparin in maintaining port patency. Additional research is needed to assess the long-term implications of using saline as a locking solution.</p>","PeriodicalId":10350,"journal":{"name":"Clinical journal of oncology nursing","volume":"29 4","pages":"329-333"},"PeriodicalIF":1.2,"publicationDate":"2025-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12339269/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144834248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Standardizing Liposomal Doxorubicin Administration: Titration Protocol. 阿霉素脂质体给药标准化:滴定方案。
IF 1.2 4区 医学 Q3 NURSING Pub Date : 2025-08-04 DOI: 10.1188/25.CJON.334-338
Brandy Thornberry, Jenna LaRose, Poppy Wilson, Leah A Scaramuzzo

Oncology nurses working at a rural community infusion clinic observed an increase in infusion-related reactions while administering the first and second treatments of liposomal doxorubicin. Review of the package insert reveal.

在农村社区输液诊所工作的肿瘤科护士观察到,在给予阿霉素脂质体第一次和第二次治疗时,输液相关反应增加。检查包装插入显示。
{"title":"Standardizing Liposomal Doxorubicin Administration: Titration Protocol.","authors":"Brandy Thornberry, Jenna LaRose, Poppy Wilson, Leah A Scaramuzzo","doi":"10.1188/25.CJON.334-338","DOIUrl":"10.1188/25.CJON.334-338","url":null,"abstract":"<p><p>Oncology nurses working at a rural community infusion clinic observed an increase in infusion-related reactions while administering the first and second treatments of liposomal doxorubicin. Review of the package insert reveal.</p>","PeriodicalId":10350,"journal":{"name":"Clinical journal of oncology nursing","volume":"29 4","pages":"334-338"},"PeriodicalIF":1.2,"publicationDate":"2025-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12339282/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144834333","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial Intelligence in Scholarly Publishing: New Tools, Same Standards. 学术出版中的人工智能:新工具,相同标准。
IF 1.2 4区 医学 Q3 NURSING Pub Date : 2025-08-04 DOI: 10.1188/25.CJON.268-269
Joni L Watson

CJON has maintained editorial and scholarly integrity, with a commitment to publication ethics, across three decades. CJON has educated readers about the impact of ghostwritten manuscripts, authorship criteria, and embedded a.

在过去的三十年中,CJON一直保持着编辑和学术诚信,并致力于出版道德。他教育读者关于代写手稿的影响,作者标准,并嵌入了一个。
{"title":"Artificial Intelligence in Scholarly Publishing: New Tools, Same Standards.","authors":"Joni L Watson","doi":"10.1188/25.CJON.268-269","DOIUrl":"10.1188/25.CJON.268-269","url":null,"abstract":"<p><p>CJON has maintained editorial and scholarly integrity, with a commitment to publication ethics, across three decades. CJON has educated readers about the impact of ghostwritten manuscripts, authorship criteria, and embedded a.</p>","PeriodicalId":10350,"journal":{"name":"Clinical journal of oncology nursing","volume":"29 4","pages":"268-269"},"PeriodicalIF":1.2,"publicationDate":"2025-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12339272/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144834241","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Only the Best Is Acceptable. 只有最好的才能被接受。
IF 1.2 4区 医学 Q3 NURSING Pub Date : 2025-08-04 DOI: 10.1188/25.CJON.270-271
Marcia Liebman

To commemorate ONS's 50th anniversary in 2025, throughout the year, we will be reprinting seminal editorials written by former editors of the Oncology Nursing Forum and the Clinical Journal of Oncology Nursing that have.

为了纪念2025年ONS成立50周年,在这一年中,我们将重印由肿瘤护理论坛和肿瘤护理临床杂志的前编辑撰写的具有开创性的社论。
{"title":"Only the Best Is Acceptable.","authors":"Marcia Liebman","doi":"10.1188/25.CJON.270-271","DOIUrl":"10.1188/25.CJON.270-271","url":null,"abstract":"<p><p>To commemorate ONS's 50th anniversary in 2025, throughout the year, we will be reprinting seminal editorials written by former editors of the Oncology Nursing Forum and the Clinical Journal of Oncology Nursing that have.</p>","PeriodicalId":10350,"journal":{"name":"Clinical journal of oncology nursing","volume":"29 4","pages":"270-271"},"PeriodicalIF":1.2,"publicationDate":"2025-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12339270/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144834249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advancing Lymphedema Surveillance With Evidence-Based Practices. 以循证实践推进淋巴水肿监测。
IF 1.2 4区 医学 Q3 NURSING Pub Date : 2025-08-04 DOI: 10.1188/25.CJON.285-290
Erin Dickman

This review examines current clinical practice guidelines and recommendations for lymphedema, focusing on the essential components of a prospective surveillance program. It synthesizes evidence-based practices recommended by.

这篇综述检查了目前的临床实践指南和淋巴水肿的建议,重点是前瞻性监测计划的基本组成部分。它综合了由。
{"title":"Advancing Lymphedema Surveillance With Evidence-Based Practices.","authors":"Erin Dickman","doi":"10.1188/25.CJON.285-290","DOIUrl":"10.1188/25.CJON.285-290","url":null,"abstract":"<p><p>This review examines current clinical practice guidelines and recommendations for lymphedema, focusing on the essential components of a prospective surveillance program. It synthesizes evidence-based practices recommended by.</p>","PeriodicalId":10350,"journal":{"name":"Clinical journal of oncology nursing","volume":"29 4","pages":"285-290"},"PeriodicalIF":1.2,"publicationDate":"2025-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12339278/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144834240","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improving Awareness of Lung Cancer Screening, Lung-RADS, and Fleischner Society Guidelines: A Critical Review. 提高对肺癌筛查、肺rads和Fleischner学会指南的认识:一项重要综述。
IF 1.2 4区 医学 Q3 NURSING Pub Date : 2025-08-04 DOI: 10.1188/25.CJON.339-344
Shannon Sprenkle, Tanya Cohn

Lung cancer is the leading cause of cancer-related deaths worldwide, yet early diagnosis is often missed in most individuals. Early screening is conducted via low-dose computed tomography (LDCT), particularly for those who ar.

肺癌是世界范围内癌症相关死亡的主要原因,但大多数人经常错过早期诊断。早期筛查是通过低剂量计算机断层扫描(LDCT)进行的,特别是对于那些患有糖尿病的人。
{"title":"Improving Awareness of Lung Cancer Screening, Lung-RADS, and Fleischner Society Guidelines: A Critical Review.","authors":"Shannon Sprenkle, Tanya Cohn","doi":"10.1188/25.CJON.339-344","DOIUrl":"10.1188/25.CJON.339-344","url":null,"abstract":"<p><p>Lung cancer is the leading cause of cancer-related deaths worldwide, yet early diagnosis is often missed in most individuals. Early screening is conducted via low-dose computed tomography (LDCT), particularly for those who ar.</p>","PeriodicalId":10350,"journal":{"name":"Clinical journal of oncology nursing","volume":"29 4","pages":"339-344"},"PeriodicalIF":1.2,"publicationDate":"2025-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12339267/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144834245","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Blinatumomab Administration in Pediatric B-Lineage ALL: Expert Recommendations From the Children's Oncology Group. 布利纳单抗在儿童b系ALL中的应用:来自儿童肿瘤组的专家建议。
IF 1.2 4区 医学 Q3 NURSING Pub Date : 2025-08-04 DOI: 10.1188/25.CJON.303-312
Holly R Kubaney, Kathleen E Montgomery, Lauren Guidry, Maki Okada, Katelyn Oranges, Shelby Smith, Megan Elizabeth Wegter, Olga Militano, Sumit Gupta, Rachel Rau, Sue Zupanec

Background: The addition of blinatumomab to chemotherapy is the new standard of care for most pediatric patients with B-lineage acute lymphoblastic leukemia (B-ALL), and its use has increased rapidly. Administering blinatumomab to pediatric patients is associated with a spectrum of unique challenges, resulting in variable practices across institutions.

Objectives: This article presents expert recommendations for blinatumomab administration in patients with pediatric B-ALL.

Methods: Pediatric oncology nurses, physicians, and pharmacists collated current evidence and Children's Oncology Group institutional experiences to identify considerations for planning for blinatumomab administration, initiating and managing infusions, and monitoring for adverse events.

Findings: Engaging patients, families, and clinicians promotes care transitions between inpatient and outpatient settings and minimizes complications. Ongoing institutional commitment to monitor and capture emerging trends in blinatumomab administration can inform future optimal care practices.

背景:对于大多数b系急性淋巴细胞白血病(B-ALL)的儿童患者,在化疗的基础上加用blinatumomab是新的治疗标准,并且其使用迅速增加。对儿科患者使用blinatumumab具有一系列独特的挑战,导致各机构的实践各不相同。目的:本文提出了布利纳单抗在儿童b型all患者中应用的专家建议。方法:儿科肿瘤护士、医生和药剂师整理了现有证据和儿童肿瘤组的机构经验,以确定规划布利纳单抗给药、启动和管理输液以及监测不良事件的考虑因素。研究结果:患者、家属和临床医生的参与促进了住院和门诊之间的护理转变,并最大限度地减少了并发症。持续的机构承诺监测和捕捉布利纳单抗管理的新趋势,可以为未来的最佳护理实践提供信息。
{"title":"Blinatumomab Administration in Pediatric B-Lineage ALL: Expert Recommendations From the Children's Oncology Group.","authors":"Holly R Kubaney, Kathleen E Montgomery, Lauren Guidry, Maki Okada, Katelyn Oranges, Shelby Smith, Megan Elizabeth Wegter, Olga Militano, Sumit Gupta, Rachel Rau, Sue Zupanec","doi":"10.1188/25.CJON.303-312","DOIUrl":"10.1188/25.CJON.303-312","url":null,"abstract":"<p><strong>Background: </strong>The addition of blinatumomab to chemotherapy is the new standard of care for most pediatric patients with B-lineage acute lymphoblastic leukemia (B-ALL), and its use has increased rapidly. Administering blinatumomab to pediatric patients is associated with a spectrum of unique challenges, resulting in variable practices across institutions.</p><p><strong>Objectives: </strong>This article presents expert recommendations for blinatumomab administration in patients with pediatric B-ALL.</p><p><strong>Methods: </strong>Pediatric oncology nurses, physicians, and pharmacists collated current evidence and Children's Oncology Group institutional experiences to identify considerations for planning for blinatumomab administration, initiating and managing infusions, and monitoring for adverse events.</p><p><strong>Findings: </strong>Engaging patients, families, and clinicians promotes care transitions between inpatient and outpatient settings and minimizes complications. Ongoing institutional commitment to monitor and capture emerging trends in blinatumomab administration can inform future optimal care practices.</p>","PeriodicalId":10350,"journal":{"name":"Clinical journal of oncology nursing","volume":"29 4","pages":"303-312"},"PeriodicalIF":1.2,"publicationDate":"2025-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12339268/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144834242","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Do We Need to Come Home to the Sacred in Oncology Nursing? 我们需要回到肿瘤护理的神圣之处吗?
IF 1.2 4区 医学 Q3 NURSING Pub Date : 2025-08-04 DOI: 10.1188/25.CJON.352
Liz Cooke

When I began as a nurse, there were no targeted agents; no granulocyte-colony-stimulating factors; no sophisticated antibiotics, antivirals, or antifungals; and no electronic health records. Palliative care and survivorship.

当我刚开始当护士时,还没有针对性的药物;无粒细胞集落刺激因子;没有复杂的抗生素、抗病毒药物或抗真菌药物;也没有电子健康记录姑息治疗和生存。
{"title":"Do We Need to Come Home to the Sacred in Oncology Nursing?","authors":"Liz Cooke","doi":"10.1188/25.CJON.352","DOIUrl":"10.1188/25.CJON.352","url":null,"abstract":"<p><p>When I began as a nurse, there were no targeted agents; no granulocyte-colony-stimulating factors; no sophisticated antibiotics, antivirals, or antifungals; and no electronic health records. Palliative care and survivorship.</p>","PeriodicalId":10350,"journal":{"name":"Clinical journal of oncology nursing","volume":"29 4","pages":"352"},"PeriodicalIF":1.2,"publicationDate":"2025-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12339275/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144834243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Randomized Multicenter Trial of Acupressure in Patients Undergoing Moderately to Highly Emetogenic Chemotherapy. 穴位按压在中度至高度致吐性化疗患者中的随机多中心试验。
IF 1.2 4区 医学 Q3 NURSING Pub Date : 2025-08-04 DOI: 10.1188/25.CJON.313-320
Delmy Oliva, Mats Nilsson, Elsy-Britt Schildt, Lisa Fust, Emma Larsson, Ulrika Åsenlund, Ellinor Elinder, Ida Sörling Mannervik, Freddi Lewin

Background: Chemotherapy can contribute to chemotherapy-induced nausea and vomiting (CINV). The use of acupressure is a nonpharmacologic method to counteract general nausea and vomiting.

Objectives: The primary end point was to determine whether there were any differences in CINV episodes between patients receiving acupressure at two different acupressure points.

Methods: Patients (N = 509) were randomized between acupressure at the Pericardium 6 point and the Triple Warmer 5 point. Patients reported data in a structured diary for 10 days and health-related quality of life using a questionnaire on days 1 and 10.

Findings: Regardless of group, 70 patients reported having decreased global health status after the first chemotherapy treatment. There was no difference in the occurrence or intensity of CINV between acupressure applied at the two different points. Antiemetic prophylaxis remains the most important method of counteracting CINV.

背景:化疗可导致化疗引起的恶心和呕吐(CINV)。穴位按压是一种非药物治疗恶心和呕吐的方法。目的:主要终点是确定在两个不同穴位接受穴位按压的患者之间CINV发作是否有任何差异。方法:509例患者随机分为心包穴位6点和三温穴位5点两组。患者在10天的结构化日记中报告数据,并在第1天和第10天使用问卷调查报告与健康相关的生活质量。研究结果:无论分组如何,70例患者报告首次化疗后整体健康状况下降。穴位按压在两个穴位上的CINV发生率和强度没有差异。止吐预防仍然是对抗CINV的最重要方法。
{"title":"Randomized Multicenter Trial of Acupressure in Patients Undergoing Moderately to Highly Emetogenic Chemotherapy.","authors":"Delmy Oliva, Mats Nilsson, Elsy-Britt Schildt, Lisa Fust, Emma Larsson, Ulrika Åsenlund, Ellinor Elinder, Ida Sörling Mannervik, Freddi Lewin","doi":"10.1188/25.CJON.313-320","DOIUrl":"10.1188/25.CJON.313-320","url":null,"abstract":"<p><strong>Background: </strong>Chemotherapy can contribute to chemotherapy-induced nausea and vomiting (CINV). The use of acupressure is a nonpharmacologic method to counteract general nausea and vomiting.</p><p><strong>Objectives: </strong>The primary end point was to determine whether there were any differences in CINV episodes between patients receiving acupressure at two different acupressure points.</p><p><strong>Methods: </strong>Patients (N = 509) were randomized between acupressure at the Pericardium 6 point and the Triple Warmer 5 point. Patients reported data in a structured diary for 10 days and health-related quality of life using a questionnaire on days 1 and 10.</p><p><strong>Findings: </strong>Regardless of group, 70 patients reported having decreased global health status after the first chemotherapy treatment. There was no difference in the occurrence or intensity of CINV between acupressure applied at the two different points. Antiemetic prophylaxis remains the most important method of counteracting CINV.</p>","PeriodicalId":10350,"journal":{"name":"Clinical journal of oncology nursing","volume":"29 4","pages":"313-320"},"PeriodicalIF":1.2,"publicationDate":"2025-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12339283/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144834331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinical journal of oncology nursing
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1